New On Robinhood

Inozyme Pharma

$27.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.85 (+3.23%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Inozyme Pharma and other stocks, options, and ETFs commission-free!

About INZY

Inozyme Pharma engages in the research and development of pharmaceutical products. It specializes in developing new medicines for the treatment of abnormal mineralization and ABCC6 deficiency. The company was founded by Axel Bolte, Joseph P. Schlessinger and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA. The listed name for INZY is Inozyme Pharma, Inc. Common Stock.

CEO
Axel Bolte
Employees
—
Headquarters
Boston, Massachusetts
Founded
2015
Market Cap
635.04M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
36.36K
High Today
$28.40
Low Today
$26.06
Open Price
$26.18
Volume
45.05K
52 Week High
$31.65
52 Week Low
$16.10

Collections

INZY Earnings

-$7.57
-$5.05
-$2.52
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 25, Pre-Market

You May Also Like

COM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure